Archives2023202220212020201920182017201620152014201320122011 November 18, 2022Avion confirms its continued support to the Lupuzor™ clinical program in Lupus whilst exploring broader collaboration opportunities Read More September 30, 2022Lupuzor™ Update Read More September 30, 2022INTERIM RESULTS for the six months ended 30 June 2022 Read More September 15, 2022Written response received from the FDA Read More September 07, 2022Exercise of Options | L1 Capital Read More August 31, 2022FDA response for Type C Meeting – update Read More August 31, 2022Exercise of Options Read More August 24, 2022Exercise of Options Read More August 18, 2022Lanstead Capital TR1 Read More August 16, 2022Total Voting Rights Read More August 11, 2022Result of Broker Option / PDMR Dealings Read More August 04, 2022INVESTOR PRESENTATION Via Investor Meet Company Platform | 12 midday (BST) | 4 August 2022 Read More 12345…20
November 18, 2022Avion confirms its continued support to the Lupuzor™ clinical program in Lupus whilst exploring broader collaboration opportunities Read More
August 04, 2022INVESTOR PRESENTATION Via Investor Meet Company Platform | 12 midday (BST) | 4 August 2022 Read More
